Instrumento Inactivo

Acciones Cadence Pharmaceuticals, Inc.

Acciones

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

Actavis : Factbox - M&A frenzy transforming global pharma	06/05/14
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results	28/02/14
Cadence Pharmaceuticals, Inc. : Ryan & Maniskas, LLP Announces Investigation of Cadence Pharmaceuticals Inc.	12/02/14
Cadence Pharmaceuticals, Inc. : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Cadence Pharmaceuticals, Inc. Stockholders	11/02/14
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Estimates Fourth Quarter and Full Year 2013 Product Revenue and Provides Full Year 2014 Revenue Guidance	13/01/14

Directores	Puesto	Edad	Desde
Bryan Reasons PSD	President	56	-
Diane K. Sheehan HRO	Human Resources Officer	54	01/05/06

Administradores	Puesto	Edad	Desde
Bryan Reasons PSD	President	56	-
Marvin R. Haselhorst BRD	Director/Board Member	-	19/03/14

Sector

	Varia. 1 de ene.	Capi.
CSL LIMITED	+2,99 %	95,18 mil M
SAMSUNG BIOLOGICS CO.,LTD.	-4,34 %	37,55 mil M
UCB	+75,79 %	28,2 mil M
BIOMARIN PHARMACEUTICAL INC.	-14,61 %	15,63 mil M
INCYTE CORPORATION	-3,46 %	13,63 mil M
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12,31 %	11,5 mil M
ALTEOGEN INC.	+184,77 %	10,81 mil M
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-54,13 %	9233,36 M
SWEDISH ORPHAN BIOVITRUM AB	+6,22 %	9093,99 M